OmniComm Systems Signs First TrialMaster® Customer in China

FORT LAUDERDALE, Fla., Apr. 10 (Korea Bizwire) — Shanghai HEP Pharma Co. LTD, a research and development company focused on developing innovative drugs for hepatitis B, has signed a new agreement with OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology. Under the agreement, Shanghai HEP Pharma will use OmniComm’s TrialMaster [...]